期刊文献+

新诊断2型糖尿病患者血清对氧磷酶3水平与颈动脉粥样硬化的相关性 被引量:10

Association of serum pon3 with carotid atherosclerosis in newly diagnosed T2DM patients
原文传递
导出
摘要 目的探讨T2DM患者血清对氧磷酶3(pon3)水平与血糖、血脂、IR等代谢因素及T2DM早期颈动脉粥样硬化(CAS)的关系。方法选择新诊断T2DM患者108例,根据有无CAS分为合并CAS(A,53例)组和不合并颈动脉斑块(B,55例)组;另选择健康体检者为对照(C,54例)组。采用ELISA方法测定空腹血清pon3水平,检测血脂、同型半胱氨酸(Hcy)、纤维蛋白原(Fib)、HbA1c、FPG、hsC-RP、超氧化物歧化酶(SOD)等指标,采用稳态模型评估胰岛素抵抗指数(HOMA-IR)。结果 3组血清pon3水平依次为:C组(2.24±0.44)ng/ml<B组(2.72±0.51)ng/ml<A组(3.58±0.62)ng/ml(P<0.05或P<0.01);血清pon3水平与BMI、FIns、TC、HOMA-IR、hsC-RP、FPG、HbA1c、Hcy、Fib呈正相关(r分别为0.513、0.523、0.593、0.529、0.517、0.487,0.487、0.547,0.528,P<0.05或P<0.01),与HDL-C、SOD负相关(r=-0.497,-0.589)。多元逐步回归分析显示,BMI、hsC-RP、LDL-C、Fib是影响T2DM患者pon3的独立相关因素。Logistic回归分析显示,BMI、Fib、LDL-C、pon3是T2DM发生CAS的主要影响因素。结论血清pon3在新诊断T2DM合并颈动脉斑块人群中升高,在新诊断T2DM合并CAS的发生中起重要作用。 Objective To explore the association of serum paraoxonase-3 (pon3) with serum glucose, lipid, insulin resistance, and the carotid atherosclerosis (CAS) in the newly diagnosed T2DM patients. Method The 108 patients with newly diagnosed T2DM were divided into T2DM with CAS group (Group A, n=53), and T2DM without CAS group (Group B, n=55). The 54 healthy people with normal glucose tolerance were selected as the controls (Group C). Serum pon3 was measured with the ELISA method. FPG, 2 hPG, FIns, HbA1c, hsC-RP, and lipid profiles, homocysteine (Hcy), fibrinogen (Fib), and superoxide dismutase (SOD) were measured as well. BMI and waist-to-hip ratio (WHR) were recorded and insulin sensitivity was assessed by HOMA-IR. Results The serum pon3 levels of the three groups were in an order of Group C (2.24±0.44) 〈 Group B (2.72±0.51) ng/mg/ml〈Group A (3. 584-0. 62)ng/mg/ml (P〈0. 05 or P〈0. 01). The pon3 level was positively correlated with BMI, Fins, TC, HOMA-IR, hsC-RP, FPG, HbAlc, Hcy, and Fib (r=0. 513, 0. 523, 0. 593, 0. 529, 0. 517, 0. 487, 0.487, 0. 547, 0. 528 respectively (P〈0. 05 or P〈0. 01), and negatively correlated with HDL-C and SOD (r=-0. 647,-0. 589 ,P〈0. 01). Multiple stepwise regression analysis showed that BMI, hsC-RP, LDL-C, and Fib were the independent related {actors influencing the plasma pon3 level o{ T2DM patients. Logistic regression analysis showed that BMI, Fib, LDL-C, and the fasting serum pon3 levels were the main factors for macrovascular complications in T2DM Conclusion Serum pon3 is in a higher level and plays a very important role in newly diagnosed T2DM patients accompanied with CAS.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2014年第1期47-50,共4页 Chinese Journal of Diabetes
关键词 对氧磷酶3 糖尿病 2型 颈动脉粥样硬化 Paraoxonase-3 (pon3) Diabetes mellitus, type 2 Carotid atherosclerosis (CAS)
  • 相关文献

参考文献10

  • 1杨丽丽,阮秋蓉.对氧磷酶3基因研究进展[J].中国动脉硬化杂志,2012,20(10):945-950. 被引量:6
  • 2Rull A, Garcia R. Femdndez-Sender L. et al. Serum paraoxonase-3 concentration is associated with insulin sensitivity in peripheral artery disease and with inflammation in coronary artery disease. Atherosclerosis. 2012. 20: 945-950.
  • 3Labrecque B. Beaudry D. Mayhue M. et al, Molecular characterization and expression analysis of the porcine paraoxonase 3 (PON3) gene. Gene. 2009. 443: 110-120.
  • 4Peng W. Zhang C. Lv H. et al. Comparative evaluation of the protective potentials of human paraoxonase 1 and 3against CCI4 induced liver injury. Toxicol Lett. 2010. 193:159-166.
  • 5Qasim A. Mehta NN. Tadesse MG. et al. Adil'okines , insulinresistanee , and Eoronary artery calcification. ] ain Coil Cardiol , 2008.52:231-236.
  • 6Ng CJ, Bourquard N, Hama SY. et al. Adenovirus-mediated expression of human paraoxonase 3 protects against the progression of atherosclerosis in apolipoprotein E-deficient mice the progression of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vase Bioi. 2007. 27: 1368-1374.
  • 7She ZG. Chen HZ. Yan Y, et al. The human paraoxonase gene cluster as a target in the treatment of atherosclerosis. Antioxid Redox Signal, 2012. 16: 597-632.
  • 8Murakami H, Tanabe]. Tamasawa N. et al. Reduction of paraoxonase-l activity may contribute the qualitative impairment of HDL particles in patients with type 2 diabetes. Diabetes Res Clin Pract , 2013. 99: 30-38.
  • 9Sanghera DK, Manzi S. Minster RL, et al. Genetic variation in the paraoxonase-3 (PON3) gene is associated with serum PONI activity. Ann Hum Genet. 2008: 72-81.
  • 10Schweikert EM. Devarajan A. Witte i, et al. PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell death. Cell Death Differ. 2012, 19: 1549-1560.

二级参考文献32

  • 1Primo-Parmo SL, Sorenson RC, Teiber J, et al. The hu- man serum paraoxonase/arylesterase gene (PON) is one member of a multigene family [ J ]. Genomics, 1996, 33 : 498-507.
  • 2Reddy ST, Wadleigh DJ, Grijalva V, et al. Human parao- xonase-3 is an HDL-associated enzyme with biological ac- tivity similar to paraoxonase-1 protein but is not regulated by oxidized lipids [ J ]. Arterioscler Thromb Vasc Biol, 2001, 21 (4) : 542-547.
  • 3Ng C J, Wadleigh D J, Gangopadhyay A, et al. Paraoxo- nase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxida- tive modification of low density lipoprotein [ J ]. J Biol Chem, 2001, 276:44 444-449.
  • 4Costa LG, Cole TB, Vitalone A, et al. Measurement of paraoxonase ( PON1 ) status as a potential biomarker of sus- ceptibility to organophosphate toxicity [ J ]. Clin Chim Ac- ta, 2005, 352 (1-2): 37-47.
  • 5Draganov DI, Teiber JF, Speelman A, et al. Human para- oxonase (PON1, PON2, and PON3) are lactonase with o- verlapping and distinct substrate specificities [ J ]. J Lipid Res, 2005, 46:1 239-247.
  • 6Draganov DI, Stetson PL, Watson CE, et al. Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associ- ated lactonase and protects low density lipoprotein against oxidation[J]. J Biol Chem, 2000, 275:33 435-442.
  • 7Aviram M, Billecke S, Sorenson R, et al. Paraoxonase ac- tive site required for protection against LDL oxidation in- volves its free sulfhydryl group and is different from that re- quired for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R[ J]. Arte- rioscler Thromb Vasc Biol, 1998. 18 : 1 617-624.
  • 8Campo S, Sardo AM, Campo GM, et al. Identification of paraoxonase 3 gene (PON3) missense mutations in a popu- lation of southern Italy[J]. Murat Res, 2004, 546 (1-2) : 75-80.
  • 9Sanghera DK, Manzi S, Minster RL, et al. Genetic varia- tion in the paraoxonase-3 (PON3) gene is associated with serum PON1 activity[J]. Genet, 2008, 72 (1): 72-81.
  • 10Labrecque B, Beaudry D, Mayhue M, et al. Molecular characterization and expression analysis of the porcine paraoxonase 3 ( PON3 ) gene [ J ]. Gene, 2009, 443 ( 1- 2) : 110-120.

共引文献5

同被引文献43

引证文献10

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部